Company Filing History:

25 out of 1,858

Takeda Chemical Industries, Inc.

Takeda Pharmaceutical Company Limited

where one patent can have more than one assignee

Years Active: 1976-2020

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10809262 - Multiplex colon cancer marker panel (2020-10-20),

2. 9079972 - Method of screening a substance for improving insulin resistance (2015-07-14),

3. 7892846 - Phosphopeptide analysis method (2011-02-22),

4. 7354996 - Method and kit for quantitative analysis of protein (2008-04-08),

5. 7348324 - Cyclic amine compounds as CCR5 antagonists (2008-03-25),

6. 6936602 - Benzazepine derivatives, process for the preparation of the same and uses thereof (2005-08-30),

7. 6838259 - Process for producing kiss-1 peptide (2005-01-04),

8. 6825165 - Betacellulin modification (2004-11-30),

9. 6787650 - Urea compounds, process for producing the same and use thereof (2004-09-07),

10. 6774221 - Process for eliminating N-terminal methionine (2004-08-10),

11. 6627651 - Cyclic compounds and uses thereof (2003-09-30),

12. 6562978 - Cyclic amine compounds as CCR5 antagonists (2003-05-13),

13. 6376536 - Quaternary ammonium salts and their use (2002-04-23),

14. 6309859 - Method for removing N-terminal methionine (2001-10-30),

15. 6287806 - Method for producing a biologically active recombinant cysteine-free peptide (2001-09-11),

Osamu Nishimura: Innovator in Colon Cancer and Insulin Resistance Research

Introduction

Osamu Nishimura, based in Kawanishi, Japan, is a prolific inventor with an impressive portfolio of 30 patents. His groundbreaking work primarily focuses on the early detection of colon cancer and the evaluation of insulin resistance, leading to significant advancements in medical diagnostics and therapeutic strategies.

Latest Patents

Nishimura's recent innovations include the development of a multiplex colon cancer marker panel. This invention provides a specific combination of colon cancer markers based on statistical knowledge, allowing for the detection of a greater number of colon cancer patients at earlier stages while maintaining high specificity. The panel comprises five critical colon cancer markers: Carcinoembryonic antigen-related cell adhesion molecule 5, Carbohydrate antigen 19-9, Galectin-4, APEX nuclease, and Actin-related protein 2. Additionally, he has devised a method for analyzing these markers through the multiplex panel.

Another significant invention from Nishimura is a method for screening substances that improve insulin resistance. This patent includes an insulin resistance marker defined by a polypeptide with at least 15 continuous amino acids from a specific amino acid sequence, as well as a polynucleotide that encodes this sequence. These innovations present new avenues for evaluating and potentially treating insulin resistance through pharmaceutical compositions.

Career Highlights

Throughout his career, Osamu Nishimura has collaborated with leading companies such as Takeda Chemical Industries, Inc. and Shimadzu Corporation. His expertise in molecular biology and biochemistry has made him a sought-after inventor in the medical field, contributing significantly to the advancement of health diagnostics.

Collaborations

Nishimura has worked alongside esteemed colleagues, including Masanori Baba and Naoyuki Kanzaki, fostering an environment of collaboration that has furthered innovation in medical research. These partnerships have played a crucial role in the successful development and implementation of his patented technologies.

Conclusion

Osamu Nishimura's contributions to the fields of colon cancer diagnosis and insulin resistance treatment underscore the importance of innovation in healthcare. With his remarkable patent portfolio and collaborative spirit, Nishimura continues to pave the way for transformative advancements in medical science, potentially improving countless lives through his inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.